My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$UNFI {{ '2016-05-16T12:19:39+0000' | timeago}} • Announcement

Distributor of natural & organic foods $UNFI said that it has completed its previously announced acquisition of all outstanding equity interests of Haddon House Food Products, Inc. and certain affiliated entities, as well as certain real estate. The final purchase price is subject to a customary post-closing net working capital adjustment.

User Robert Smith {{ '2017-04-26T21:13:12+0000' | timeago}}

$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.

User Leroy John {{ '2017-04-26T21:11:32+0000' | timeago}}

$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.

User Irene Grennan {{ '2017-04-26T21:08:01+0000' | timeago}}

Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.

User Barbara Salley {{ '2017-04-26T17:50:03+0000' | timeago}}

Back with a bang! $TWTR

User Amelita Yates {{ '2017-04-26T17:23:10+0000' | timeago}}

Even though $TMUS is behind $VZ and $T, it is playing catchup in style! 1.1 million new subscribers in Q1!!

$BSX {{ '2017-04-27T11:12:47+0000' | timeago}} • Announcement

$BSX now estimates revenue for FY17 in a range of $8.8-8.9Bil (compared to prior guidance of $8.675-8.875Bil). Net income is expected between $0.81 and $0.86 per share (compared to prior guidance of $0.86-0.91 per share). Adjusted earnings outlook was reaffirmed at a range of $1.22-1.26 per share.

$BSX {{ '2017-04-27T11:08:18+0000' | timeago}} • Announcement

$BSX's sales in 1Q17 rose to $2.16Bil, helped by revenue growth in all segments. In a YoY basis, MedSurg revenue jumped 15%; Cardiovascular grew 8%; and Rhythm Management increased 7%.

$BSX {{ '2017-04-27T11:01:45+0000' | timeago}} • Announcement

Medical device maker $BSX reported 10% growth in revenue in 1Q17, which helped it post higher earnings. Net earnings were $290MM or $0.21 per share, compared to $202 million or $0.15 per share a year ago. On an adjusted basis, net earnings grew to $0.29 per share.

$IRM {{ '2017-04-27T10:50:20+0000' | timeago}} • Announcement

$IRM still expects 2017 revenue growth of 8-10% on constant dollar basis, to $3.75-3.84Bil, adjusted EBITDA growth of 16-19% to $1.25-1.28Bil and adjusted FFO growth of 8-15% to $715-760MM. The company still predicts adjusted EPS of $1.15-1.25, which reflects a 8-18% growth year-over-year.

$IRM {{ '2017-04-27T10:50:05+0000' | timeago}} • Announcement

$IRM posted normalized funds from operations per share of $0.48, compared with $0.53 in the previous year quarter. FFO per share reflects a structural tax rate of 23.1% compared with a structural tax rate of 14% in 1Q16. The company reported adjusted FFO of $170.94MM during the quarter compared with $167.57MM in 1Q16.